Shares of Can-Fite BioPharma Ltd. CANF surged 30.5% after the company announced its strategic partnership with Univo to develop cannabinoid-based products is ongoing.Shares of Immunomedics, Inc. IMMU gained 5.7% after the company announced that the FDA had accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.Shares of Spring Bank Pharmaceuticals, Inc. SBPH declined 66.8% after the company reported that it has stopped the dosing of inarigivir patients in Phase 2 program.Shares of QIAGEN N.V. QGEN declined 20.6% after the company announced that it would not be acquired and will stay a standalone business.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report QIAGEN N.V. (QGEN): Free Stock Analysis Report Immunomedics, Inc. (IMMU): Free Stock Analysis Report Can-Fite Biopharma Ltd (CANF): Free Stock Analysis Report Spring Bank Pharmaceuticals, Inc. (SBPH): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research